It was found that Dong-A ST applied for permission to the MFDS for Forxiga (Dapagliflozin Propanediol Hydrate, AZ), which has been devoted to development. Dong-A ST succeeded in avoiding material patents (scheduled to expire on April 7, 2023) through prodrug for Forxiga, so there is a possibility that it will dominate the generic market when commercialization is completed.

According to the pharmaceutical industry on the 6th, Dong-A ST recently applied for permission to the MFDS for prodrug for Forxiga. Prodrug improves it slightly differently from the original substance. Prodrug differs from simple salt changes because the chemical structure is partially changed.

Dong-A ST focused on avoi